Result card

  • EFF4: Does adjuvant therapy on the basis of uPA/PAI, Mammaprint, or Oncotype test results compared to treatment on the basis of the standard practice affect their activities of daily living?
English

Does adjuvant therapy on the basis of uPA/PAI, Mammaprint, or Oncotype test results compared to treatment on the basis of the standard practice affect their activities of daily living?

Authors: Authors: Mirjana Huic, Narine Sahakyan, Gurleen Jhuti, Anna Panasiuk, Heike Raatz, Petra Schnell-Inderst, Katarzyna Sejbuk, Eva Turk, Marjetka Jelenc

Internal reviewers: Luciana Ballini, Patricia Harrington, Stefan Lange, Michelle O'Neill, Paolo Giorgo Rossi, Stefan Sauerland, Luca Vignatelli, Siw Waffenschmidt

Acknowledgments: Jayne Hickton (Information Specialist, NICE)

No studies that addressed this question were identified.

Optional
Partially
Huic A et al. Result Card EFF4 In: Huic A et al. Clinical Effectiveness In: Jefferson T, Vicari N, Raatz H [eds.]. Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX ) [Core HTA], Agenzia nationale per i servizi sanitari regionali (age.na.s), Italy ; 2013. [cited 2 December 2022]. Available from: http://corehta.info/ViewCover.aspx?id=113